TABLE 2

Each Patient’s Detail

				Primary lesions
Patient no.	Age (y)	Sex	Tumor site	PET	CT	FNAB	Primary SUVs	Neck node SUVs	Tumor size	Metastasis	Status
1	67	M	PRT	+	+	H-G ca	1.8	NU	2.5		NED
2	57	F	SL	+	+	L-G ca	4.7	5.9	9	T, N, M	DOD
3	46	F	PRT	+	+	Metastatic carcinoma	8	8	2.5		NED
4	40	M	PRT	+	+	H-G ca	4.9	5.2	2.3	N, M	DOD
5	62	M	PRT	+	+	Carcinoma	3.5	1.7	4.8		NED
6	64	M	PRT	+	+	H-G ca	8.3	1.7	4		NED
7	66	M	SMG	+	+	Carcinoma	4.6	6.8	1.7	M	DOD
8	49	M	PRT	+	+	H-G ca	4	2	6		NED
9	56	M	PRT	+	+	H-G ca	5.7	NU	2		NED
10	73	M	SMG	+	+	SDC	12.1	NU	1.5		NED
11	60	F	SMG	+	+	SDC	10.7	13	3.7	N, M	DOD
12	50	M	SMG	+	+	SDC	7.2	7.2	5.5		NED
13	65	M	PRT	+	-	L-C ca	2.2	3	1.3	M	DOD
14	64	M	PRT	+	+	H-G ca	2	2	3.1	M	DOD
15	72	M	SMG	+	+	MEC	3.2	5	2.7	T, N, M	AWD
16	69	F	PRT	+	+	NSC	4.3	8.6	2.2		NED
17	47	M	SMG	+	+	H-G ca	4.7	5.8	1.8		NED
18	39	M	PRT	+	+	H-G ca	11.8	10	2.7		NED

PRT = parotid gland; H-G ca = high-grade carcinoma; NU = no uptake; NED = no evidence of disease; SL = sublingual gland; L-G ca = low-grade carcinoma; DOD = die of disease; SMG = submandibular gland; SDC = salivary duct carcinoma; L-C ca = large cell carcinoma; MEC = mucoepidermoid carcinoma; AWD = alive with disease; NSC = non–small cell carcinoma.